Matthew Paulson Overview

  • Investor Type
  • Angel
  • Investments
  • 4
  • Portfolio
  • 2
  • Exits
  • 2
Exits

Matthew Paulson General Information

Description

Mr. Matthew Paulson is an Angel Investor.

Contact Information

Primary Investor Type
Angel (individual)

Matthew Paulson Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Prismatic (Software Development Applications) 28-Apr-2021 Seed Round 00.000 Media and Information Services (B2B) Generating Revenue 0000000 0000000
0000000 0000000000 12-Jul-2018 00000 00000 00000 Drug Discovery Clinical Trials - Phase 1 0000000 0000000
PhoneWagon 01-Apr-2018 Seed Round 00.00 Business/Productivity Software Generating Revenue 0000000 0000000
LendStreet 06-Oct-2015 Seed Round 000 Consumer Finance Generating Revenue 0000000 0000000
To view Matthew Paulson’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Matthew Paulson Exits (2)

Company Name Exit Date Exit Type Exit Size
Compass Therapeutics 04-Nov-2021 IPO 00000
0000000000 06-May-2021 000000000000000000
To view Matthew Paulson’s complete exits history, request access »

Matthew Paulson Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Matthew Paulson Team (1)

Name Title Deals Funds Boards Office
Matthew Paulson Angel Investor 0
To view Matthew Paulson’s complete team members history, request access »

Matthew Paulson Co-Investors (33)

Name With Exits Lead Partner Series Industry
BioMed Realty 1 0 Series chart Industry bar
Birchmere Ventures 0 0 0 Series chart Industry bar
Borealis Ventures 0 0 Series chart Industry bar
Eight Roads 0 0 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
You’re viewing 5 of 33 co-investors. Get the full list »